logo
Plus   Neg
Share
Email

GSK: FDA Approves ViiV Healthcare's Dovato - Quick Facts

GlaxoSmithKline plc (GSK.L,GSK) reported that ViiV Healthcare announced the US FDA approved Dovato, a once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC) 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral treatment history and with no known resistance to either DTG or 3TC.

DTG/3TC as a once-daily, single-tablet, two-drug regimen for HIV-1 therapy is currently under review by the European Medicines Agency and regulatory authorities in Canada, Australia, Switzerland, and South Africa and several additional submissions are planned throughout 2019.

ViiV Healthcare is a global specialist HIV company established in 2009 by GlaxoSmithKline and Pfizer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
FedEx Corp. said it missed delivery of a Huawei Technologies package in the U.S. due to an "operational error" and has apologized for the incident, according to reports. The package delivery giant also reportedly said it will accept and deliver all Huawei products, except for shipments to addresses of Huawei and affiliates listed on the U.S. Entity List. Toy retailer Toys "R" Us, which shut down U.S. operations in June 2018, is said to be returning to the market, with plans of opening about half a dozen U.S. stores and an e-commerce site before the Christmas holiday season 2019. The proposed new stores in the US are to be of 10,000 square feet, roughly the third of the size of the big box brand that closed last year. Perrigo Company plc has recalled an infant formula only sold at Walmart due to a potential presence of metal. Perrigo has recalled 35-ounce, 992-gram containers of Parent's Choice Advantage Infant Formula Milk-Based Powder with Iron. This product is being recalled because of the potential presence...
Follow RTT